SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,809,402 | -33.4% | 138,172 | -27.3% | 0.70% | -29.6% |
| Q2 2023 | $5,716,781 | +19.6% | 190,179 | +44.2% | 0.99% | -4.6% |
| Q1 2023 | $4,777,940 | +41.1% | 131,878 | +39.0% | 1.04% | +15.3% |
| Q4 2022 | $3,385,297 | +11.5% | 94,906 | +5.8% | 0.90% | +4.4% |
| Q3 2022 | $3,037,000 | +18.4% | 89,709 | +1.2% | 0.86% | -8.6% |
| Q2 2022 | $2,564,000 | -27.2% | 88,658 | -18.6% | 0.94% | -8.3% |
| Q1 2022 | $3,521,000 | +15.3% | 108,954 | +4.0% | 1.03% | +52.8% |
| Q4 2021 | $3,053,000 | +14.0% | 104,714 | +4.3% | 0.67% | -0.6% |
| Q3 2021 | $2,678,000 | -13.4% | 100,415 | 0.0% | 0.68% | +0.3% |
| Q2 2021 | $3,092,000 | – | 100,415 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |